• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Avinash Gupta, Sharon Love, +12 authors Mark R. Middleton
  • Medicine
  • Annals of oncology : official journal of the…
  • 2014 (First Publication: 1 May 2014)
  • BACKGROUND Treatment options for wild-type BRAF melanoma patients remain limited. Selumetinib, a MEK 1/2 inhibitor, suppresses pERK levels independent of BRAF and NRAS mutation status, andContinue Reading
  • Phyllis N Butow, Jane W. Turner, +13 authors Belinda Thewes
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2017 (First Publication: 20 December 2017)
  • Purpose Fear of cancer recurrence (FCR) is prevalent, distressing, and long lasting. This study evaluated the impact of a theoretically/empirically based intervention (ConquerFear) on FCR. MethodsContinue Reading
  • Ross J S Calopedos, Venu Chalasani, Rebecca Asher, Louise Emmett, Henry H Woo
  • Medicine
  • Prostate Cancer and Prostatic Diseases
  • 2017 (First Publication: 1 September 2017)
  • Background:Promising therapeutic results of the prostate-specific membrane antigen (PSMA) ligand have been shown when labelling with lutetium-177 (177Lu). We performed a systematic review andContinue Reading
  • Sreedhar Subramanian, Rebecca Asher, +8 authors Jonathan M. Rhodes
  • Medicine
  • Inflammatory bowel diseases
  • 2016 (First Publication: 1 August 2016)
  • BACKGROUND Various physician- and patient-reported instruments exist for quantification of disease activity in inflammatory bowel diseases (IBD) but none are widely used in routine clinical practice.Continue Reading
  • Ashley Bond, Rebecca Asher, +6 authors Sreedhar Subramanian
  • Medicine
  • European journal of gastroenterology & hepatology
  • 2016 (First Publication: 1 March 2016)
  • INTRODUCTION Optimal trough levels of the anti-tumour necrosis factor agents, infliximab and adalimumab, are correlated with clinical remission. Obesity adversely affects response to infliximab andContinue Reading
  • Jennifer K Mooi, Pratyaksha Wirapati, +10 authors Niall C. Tebbutt
  • Medicine
  • Annals of oncology : official journal of the…
  • 2018 (First Publication: 21 September 2018)
  • Background The consensus molecular subtypes (CMS) is a transcriptome-based classification of colorectal cancer (CRC) initially described in early-stage cohorts, but the associations of CMS withContinue Reading
  • Susanna B Park, John B J Kwok, +4 authors Michael Friedlander
  • Medicine
  • Annals of oncology : official journal of the…
  • 2017 (First Publication: 1 November 2017)
  • Background Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting toxicity of paclitaxel, with no reliable method to identify at-risk patients. We investigated the incidence and riskContinue Reading